The Global Fund is a founding partner of the Access to COVID-19 Tools Accelerator (ACT-Accelerator). This global collaboration of leading public health agencies is working with governments, civil society and industry to accelerate the development and equitable distribution of tests, treatments and vaccines – and the strengthening of health systems – that the world needs to fight COVID-19.
The Global Fund is co-leading on three of the ACT-Accelerator’s four components – the Diagnostics Pillar, Health Systems & Response Connector and the Therapeutics Pillar.
The ACT-Accelerator has launched a transition plan for the next six months, starting on the 28 October 2022. It sets out how, as a partnership of global health agencies working alongside government, civil society and other partners, the ACT-Accelerator will support countries with long-term COVID-19 control. The changes to the ACT-Accelerator’s set-up and ways of working will ensure countries continue to have access to COVID-19 tools in the longer term and in case of disease surges.